NCT00888355
MK0954 Versus Placebo for Treatment of Mild to Moderate Hypertension
See it on ClinicalTrials.gov ↗428 people
35.3%
64.7%
151 womenmiddle line = equal numbers277 men
- Phase
- PHASE3
- Paid for by
- Merck Sharp & Dohme LLC
- Finished
- 1993-02
- Health conditions
- Hypertension
- Who could join
- Anyone
- Ages
- 21 Years – no maximum
- Average age
- mean 53.5 years
- Age 65+
- Not reported
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- White 78% · Black / African American 16.4% · Hispanic / Latina 3.7% · Other 1.9%
Women left out
- No pregnant women
Women who were pregnant could not join.
“Pregnant of lactating female patients”
- No breastfeeding moms
Women who were breastfeeding could not join.
“Pregnant of lactating female patients”
- No heart disease
Women with heart disease, heart rhythm problems or a past heart attack were turned away.
“History of myocardial infarction with in the past year”
- No cancer
Women with current or past cancer were turned away.
“Secondary hypertension or history of malignant hypertension”
Study titles and rules are shown in their original English.